038290 Macrogen

Macrogen Corp.'s Clinical NGS Laboratory Receives CAP Accreditation

Macrogen Corp. (www.macrogenlab.com) announces that its Clinical Lab that provides clinical NGS services has been awarded accreditation by the Accreditation Committee of the College of American Pathologists (CAP) based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs.

“Macrogen demonstrates leadership, innovation, and a passionate commitment to standards of excellence while providing the highest quality services, ultimately for patients,” said Bharati Jhaveri, MD, FCAP, chair of the CAP’s Council on Accreditation. “The CAP congratulates Macrogen Corp. on its recent CAP Accreditation.”

The U.S. federal government recognizes the CAP Laboratory Accreditation Program, begun in the early 1960s, as being equal-to or more-stringent-than the government’s own inspection program.

During the CAP accreditation process, designed to ensure the highest standard of care for all laboratory patients, inspectors examine the laboratory’s records and quality control of procedures for the preceding two years. CAP inspectors also examine laboratory staff qualifications, equipment, facilities, safety program and record, and overall management.

The facility’s director, Carlos Ruiz, MD, FCAP, was advised of this national recognition and congratulated for the excellence of the services being provided.

“We are very proud at Macrogen Clinical Laboratory to be a CAP Accredited laboratory in Genomic Sequencing,” said Dr. Ruiz, “The future is exciting in finding ways to improve and enhance Clinical applications utilizing whole genome and whole exome sequencing.”

About Macrogen Corp.

Macrogen Corp. (Rockville, MD), established in 2005, also shares two decades of experience of Macrogen Inc. (KOSDAQ:038290) (Seoul, Korea) in top-quality genomic sequencing and analysis. Macrogen is continually expanding both globally and with the services that it provides, including the launching of CLIA-certified services in 2012. Macrogen adapts to the fast evolving genomics field by being the first to acquire new technologies and certifications. For more information, please visit http://www.macrogenlab.com

About the College of American Pathologists

As the world’s largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. For more information, read the CAP Annual Report at cap.org.

EN
15/11/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Macrogen

 PRESS RELEASE

Macrogen Licenses Gene Editing Technology from Broad Institute of MIT ...

SEOUL, South Korea--(BUSINESS WIRE)-- Macrogen, Inc. (CEO Ji-young Moon, www.macrogen.com) (KOSDAQ: 038290), a precision medicine biotechnology company, announced on April 5 that it has acquired a non-exclusive commercial research tool license to CRISPR-Cas9 technology from the Broad Institute of MIT and Harvard in the USA, and said that the company’s gene editing technical portfolio has been further strengthened by licensing of this technology. Macrogen has acquired around 50 technologies, including the CRISPR-Cas9 portfolio...

 PRESS RELEASE

Macrogen Corp.'s Clinical NGS Laboratory Receives CAP Accreditation

ROCKVILLE, Md.--(BUSINESS WIRE)-- Macrogen Corp. (www.macrogenlab.com) announces that its Clinical Lab that provides clinical NGS services has been awarded accreditation by the Accreditation Committee of the College of American Pathologists (CAP) based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs. “Macrogen demonstrates leadership, innovation, and a passionate commitment to standards of excellence while providing the highest quality services, ultimately for patients,” said Bharati Jhav...

 PRESS RELEASE

Le laboratoire d’analyses NGS de Macrogen Corp. reçoit l’accré...

ROCKVILLE, Maryland--(BUSINESS WIRE)-- Macrogen Corp. (www.macrogenlab.com) annonce que son laboratoire d’analyses qui fournit des services cliniques NGS a été accrédité par le Comité d’accréditation du College of American Pathologists (CAP), suite aux résultats d’une récente inspection effectuée sur place dans le cadre des Programmes d’accréditation, du CAP. « Macrogen témoigne de son leadership, de ses innovations et de son engagement passionné à respecter les normes d’excellence tout en fournissant des services de q...

 PRESS RELEASE

Macrogen Established Its Branch in Spain, Strengthening Localization S...

SEOUL, South Korea--(BUSINESS WIRE)-- Macrogen Inc. (CEO Hyon-yong Chong, www.macrogen.com) (KOSDAQ:038290), a precision medicine biotechnology company, announced on Sept. 4 that it will begin providing localization service in September at its branch in Madrid, Spain. The Spanish branch of Macrogen was established last December following its first European branch in Amsterdam, Netherlands. This branch will provide quick and customer-friendly services to Southern Europe and the MENA (Middle East and North Africa) area t...

 PRESS RELEASE

Macrogen a établi une succursale en Espagne, afin de renforcer son se...

SÉOUL, Corée du Sud--(BUSINESS WIRE)-- Macrogen Inc. (CEO Hyon-yong Chong, www.macrogen.com) (KOSDAQ : 038290), une société de biotechnologie médicale de précision, a annoncé le 4 septembre que dès septembre elle offrirait, depuis sa succursale de Madrid en Espagne, un service de localisation. La succursale espagnole de Macrogen a été créée en décembre dernier après l’ouverture de sa première branche européenne à Amsterdam, aux Pays-Bas. Cette succursale fournira des services rapides et adaptés aux clients du sud de ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch